These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 16632014)
21. Predicting progression in IgA nephropathy. Bartosik LP; Lajoie G; Sugar L; Cattran DC Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875 [TBL] [Abstract][Full Text] [Related]
22. Progressive IgA nephropathy: the role of hypertension. Payton CD; McLay A; Jones JM Nephrol Dial Transplant; 1988; 3(2):138-42. PubMed ID: 3140079 [TBL] [Abstract][Full Text] [Related]
23. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824 [TBL] [Abstract][Full Text] [Related]
24. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239 [TBL] [Abstract][Full Text] [Related]
25. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411 [TBL] [Abstract][Full Text] [Related]
26. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy. Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716 [TBL] [Abstract][Full Text] [Related]
27. Vascular diseases and their risk factors in IgA nephropathy. Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659 [TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking and progression of IgA nephropathy. Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735 [TBL] [Abstract][Full Text] [Related]
29. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience. Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776 [TBL] [Abstract][Full Text] [Related]
30. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR. Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226 [TBL] [Abstract][Full Text] [Related]
31. [Some metabolic and genetic risk factors and the progression of IgA nephropathy--preliminary report]. Sulikowska B; Czarny J; Rość D; Odrowaz-Sypniewska G; Manitius J; Sliwka DM Pol Merkur Lekarski; 2006 Aug; 21(122):132-5; discussion 136. PubMed ID: 17144095 [TBL] [Abstract][Full Text] [Related]
32. Natural history of primary IgA nephropathy. Berthoux FC; Mohey H; Afiani A Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in immunoglobulin-A nephropathy. Muthukumar T; Fernando ME; Jayakumar M J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461 [TBL] [Abstract][Full Text] [Related]